Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban Safety in Recent ACS
NCT00852397Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Apr 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in acute coronary syndrome (ACS), sponsored by Pfizer. Started Apr 2009; status: terminated.
02
Drugs
apixaban
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00852397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852397.